Alpha Teknova Inc (TKNO) - Total Liabilities
Based on the latest financial reports, Alpha Teknova Inc (TKNO) has total liabilities worth $33.73 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check TKNO financial resilience to evaluate the company's liquid asset resilience ratio.
Alpha Teknova Inc - Total Liabilities Trend (2019–2025)
This chart illustrates how Alpha Teknova Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Alpha Teknova Inc.
Alpha Teknova Inc Competitors by Total Liabilities
The table below lists competitors of Alpha Teknova Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PepGen Ltd
NASDAQ:PEPG
|
USA | $21.86 Million |
|
Satellos Bioscience Inc. Common Stock
NASDAQ:MSLE
|
USA | $5.85 Million |
|
Jin Air Co Ltd
KO:272450
|
Korea | ₩949.74 Billion |
|
Havilah Resources Ltd
AU:HAV
|
Australia | AU$1.69 Million |
|
SR Accord
TA:SRAC
|
Israel | ILA1.49 Billion |
|
Capitan Silver Corp.
V:CAPT
|
Canada | CA$3.72 Million |
|
High Tide Inc
NASDAQ:HITI
|
USA | $244.82 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Alpha Teknova Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Alpha Teknova Inc (TKNO) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alpha Teknova Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alpha Teknova Inc (2019–2025)
The table below shows the annual total liabilities of Alpha Teknova Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $34.81 Million | -4.31% |
| 2024-12-31 | $36.38 Million | -5.64% |
| 2023-12-31 | $38.55 Million | -26.40% |
| 2022-12-31 | $52.38 Million | +124.71% |
| 2021-12-31 | $23.31 Million | +121.85% |
| 2020-12-31 | $10.51 Million | -76.96% |
| 2019-12-31 | $45.60 Million | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more